Updates are available Correction dated 2024-12-12
Click to view Correction: https://doi.org/10.1186/s12964-024-01988-x
-
Authors
Tettey-Matey, Abraham
Donati, Viola
Cimmino, Chiara
Di Pietro, Chiara
Buratto, Damiano
Panarelli, Mariateresa
Reale, Alberto
Calistri, Arianna
Fornaini, Maria Vittoria
Zhou, Ruhong
Yang, Guang
Zonta, Francesco
Marazziti, Daniela
Mammano, Fabio
-
Funding
Funding for this research was provided by:
Università degli Studi di Padova
- License Information
-
More Information
Article History
Received: 3 March 2024
Accepted: 28 November 2024
First Online: 5 December 2024
Change Date: 12 December 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12964-024-01988-x
Declarations
:
: Not applicable.
: This study does not contain any individual participant data. No consent to publish is required.
: G. Yang, F. Zonta and F. Mammano report a patent family: “WO2017128880 – Fully human antibody specifically inhibiting connexin 26”, Inventors: Qu Z, Yang G, Mammano F, Zonta F, International application number: PCT/CN2016/109847, granted to ShanghaiTech University; and a patent family “WO2020237491 – Composition and Methods to treat Ectodermal Dysplasia 2, Clouston Type”, Inventors: Mammano F, Yang G, Zonta F, International Application No.: PCT/CN2019/088689, pending to ShanghaiTech University. The other authors declare no competing interests.
